Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab Fixed vs Weight-Based Dosing in Rheumatoid Arthritis
NCT07582185Phase 4Not yet recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jun 2026
- Primary completion
- Sep 2026
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Centre Hospitalier Universitaire de Nice. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07582185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07582185.